Applications of nanomedicine in dermatology: Use of nanoparticles in various therapies and imaging

Journal of Cosmetic Dermatology

Volumn 9, Issue 2, 2010, Pages 154-159

  Abramovits, William ^a,b,c   Granowski, Patricia ^c   Arrazola, Peter ^c  

^a BAYLOR UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c Dermatology Treatment and Research Center   (United States)

Author keywords

Cytotoxicity; Dendrimers; Nanoparticles; Photodynamic therapy; Quantum dots

Indexed keywords

ALPHA TOCOPHEROL; ANALGESIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; COPPER OXIDE; DENDRIMER; LIPOSOME; NANOPARTICLE; NONSTEROID ANTIINFLAMMATORY AGENT; QUANTUM DOT; RETINOIC ACID; SOLID LIPID NANOPARTICLE; SUNSCREEN; TITANIUM DIOXIDE; ZINC OXIDE;

ACNE; AIR SENSITIVITY; ARTICLE; CONFOCAL MICROSCOPY; CYTOTOXICITY; DNA DAMAGE; DRUG DELIVERY SYSTEM; DRUG RELEASE; DRUG SOLUBILITY; ENCAPSULATION; EPIFLUORESCENCE MICROSCOPY; HUMAN; MEDLINE; MICROSCOPY; MINIMALLY INVASIVE PROCEDURE; NANOMEDICINE; NANOTECHNOLOGY; PHOTODYNAMIC THERAPY; PHOTOSENSITIVITY DISORDER; PHOTOSENSITIZATION; PRIORITY JOURNAL; PROPHYLAXIS; RADIATION PROTECTION; SIDE EFFECT; SKIN IRRITATION; SKIN PROTECTION; STRATUM CORNEUM; ULTRAVIOLET RADIATION;

DERMATOLOGY; HUMANS; NANOMEDICINE; NANOPARTICLES;

EID: 77954428271     PISSN: 14732130     EISSN: 14732165     Source Type: Journal    
DOI: 10.1111/j.1473-2165.2010.00492.x     Document Type: Article

References (51)

1. Jain KK. The Handbook of Nanomedicine 2008, 3-4. Totowa, NJ, Humana Press, pp
2. http://www.aananomed.org/, Available from: URL:
3. Nanotechnology Introduction. http://www.nanotech-now.com/introduction.htm, Available from: URL: Accessed March 29, 2008
4. Karlsson HL, Cronholm P, Gustafsson J. Copper oxide nanoparticles are highly toxic: a comparison between metal oxide nanoparticles and carbon nanotubes. Chem Res Toxicol 2008, 21:1726-32. Epub Aug 19, 2008
5. Nohynek GJ, Lademan J, Ribaud C. Grey goo on skin? Crit Rev Toxicol 2007, 37:251-77.
6. Weir E, Lawlor A, Whelan A, Regan F. The use of nanoparticles in anti-microbial materials and their characterization. Analyst 2008, 133:835-45. Epub Mar 12, 2008
7. Neilsen GD, Roursgaard M, Jensen KA. In vivo biology and toxicology of fullerenes and their derivatives. Basic Clin Pharmacol Toxicol 103:197-208.
8. Hirano S, Kanno S, Furuyama A. Multi-walled carbon nanotubes injure the plasma membrane of macrophages. Toxicol Appl Pharmacol 2008, 232:244-51. Epub Jul 3, 2008
9. Xia T, Kovochich M, Liong M. Comparison of the mechanism of toxicity of zinc oxide and cerium oxide nanoparticles based on dissolution and oxidative stress properties. ACS Nano 2008, 2:2121-34.
10. Friedman AJ, Han G, Navati MS. Sustained release nitric oxide releasing nanoparticle: characterization of a novel delivery platform based on nitrite containing hydrogel/glass composites. Nitric Oxide 19:12-20.
11. Martinez LR, Han G, Chacko M. Antimicrobial and healing efficacy of sustained release nitric oxide nanoparticles against Staphylococcus aureus skin infection. J Invest Dermatol 2009, 129:2463-9.
12. Auffan M, Achouak W, Rose J. Relation between the redox state of iron-based nanoparticles and their cytotoxicity toward Escherichia coli. Environ Sci Technol 2008, 42:6730-5.
13. Tang J, Xi T. Status of biological evaluation on silver nanoparticles. Sheng Wu Yi Xue Gong Cheng Xue Za Zhi 2008, 25:958-61.
14. Yang H, Liu C, Yang D. Comparative study of cytotoxicity, oxidative stress and genotoxicity induced by four typical nanomaterials: the role of particle size, shape and composition. J Appl Toxicol 2009, 29:69-78.
15. Tang M, Wang M, Xing T, Zeng J, Wang H, Ruan DY. Mechanisms of unmodified CdSe quantum dot-induced elevation of cytoplasmic calcium levels in primary cultures of rat hippocampal neurons. Biomaterials 2008, 29:4383-91. Epub Aug 26, 2008
16. Ipe BI, Lehnig M, Niemeyer CM. On the generation of free radical species from quantum dots. Small 2005, 1:706-9.
17. Hardman RA. A toxicologic review of quantum dots: toxicity depends on physicochemical and environmental factors. Environ Health Perspect 2006, 114:165-172.
18. Hoshino A, Manabe N, Fujioka K. Use of fluorescent quantum dot bioconjugates for cellular imaging of immune cells, cell organelle labeling, and nanomedicine: surface modification regulates biological function, including cytotoxicity. J Artif Organs 2007, 10:149-57. Epub Sep 20, 2007
19. Wu WH, Sun X, Yu YP. TiO2 nanoparticles promote beta-amyloid fibrillation in vitro. Biochem Biophys Res Commun 2008, 373:315-18. Epub Jun 2, 2008
20. Kang SJ, Kim BM, Lee YJ. Titanium dioxide nanoparticles trigger p53-mediated damage response in peripheral blood lymphocytes. Environ Mol Mutagen 2008, 49:399-405.
21. Park EJ, Yi J, Chung KH. Oxidative stress and apoptosis induced by titanium dioxide nanoparticles in cultured BEAS-2B cells. Toxicol Lett 2008, 180:222-9. Epub Jul 10, 2008
22. Faunce T, Murray K, Nasu H. Sunscreen safety: the precautionary principle, The Australian Therapeutic Goods Administration and nanoparticles in sunscreens. Nanoethics 2008, 2:231-40.
23. Filipe P, Silva JN, Silva R. Stratum corneum is an effective barrier to TiO(2) and ZnO nanoparticle percutaneous absorption. Skin Pharmacol Physiol. 2009, 22:266-75. Epub Aug 18, 2009
24. Baroli B, Ennas MG, Loffredo F. Penetration of metallic nanoparticles in human full-thickness skin. J Invest Dermatol 2007, 127:1701-12. Epub Mar 22, 2007
25. Mortensen LJ, Oberdörster G, Pentland AP. In vivo skin penetration of quantum dot nanoparticles in the murine model: the effect of UVR. Nano Lett 2008, 8:2779-87. Epub Aug 8, 2008
26. Dögnitz N, Salomon D, Zellweger M. Comparison of ALA- and ALA hexyl-ester-induced PpIX depth distribution in human skin carcinoma. J Photochem Photobiol B 2008, 93:140-8. Epub Aug 17, 2008
27. Bechet D, Couleaud P, Frochot C. Nanoparticles as vehicles for delivery of photodynamic therapy agents. Trends Biotechnol 2008, 26:612-21. Epub Sep 17, 2008
28. Battah S, Balaratnam S, Casas A. Macromolecular delivery of 5-aminolaevulinic acid for photodynamic therapy using dendrimer conjugates. Mol Cancer Ther 2007, 6:876-85.
29. Thassu D, Deleers M, Pathak Y. Nanoparticulate Drug Delivery Systems 2007, eds, New York, Informa Healthcare
30. Schäfer-Korting M, Mehnert W, Korting HC. Lipid nanoparticles for improved topical application of drugs for skin diseases. Adv Drug Deliv Rev 2007, 59:427-43. Epub May 3, 2007
31. Souto EB, Müller RH. Cosmetic features and applications of lipid nanoparticles (SLN, NLC). Int J Cosmet Sci 2008, 30:157-65.
32. Stecová J, Mehnert W, Blaschke T. Cyproterone acetate loading to lipid nanoparticles for topical acne treatment: particle characterisation and skin uptake. Pharm Res 2007, 24:991-1000. Epub Mar 20, 2007
33. Mojgan M, Slobodanka T, Williams S. Effects of lipid carriers on the performance of topical vehicles in vivo. J Cosmet Dermatol 2009, 8:136-43.
34. Mandawgade SD, Patravale VB. Development of SLNs from natural lipids: application to topical delivery of tretinoin. Int J Pharm 2008, 363:132-8. Epub Jul 6, 2008
35. Müller RH, Radtke M, Wissing SA. Solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in cosmetic and dermatological preparations. Adv Drug Deliv Rev 2002, 54(Suppl. 1):S131-55.
36. Kim BS, Won M, Lee KM. In vitro permeation studies of nanoemulsions containing ketoprofen as a model drug. Drug Deliv 2008, 15:465-9.
37. Kuo F, Subramanian B, Kotyla T. Nanoemulsions of an anti-oxidant synergy formulation containing gamma tocopherol have enhanced bioavailability and anti-inflammatory properties. Int J Pharm 2008, 363:206-13. Epub Jul 31, 2008
38. Wang JJ, Hung CF, Yeh CH. The release and analgesic activities of morphine and its ester prodrug, morphine propionate, formulated by water-in-oil nanoemulsions. J Drug Target 2008, 16:294-301.
39. Brisaert M, Gabriëls M, Matthijs V. Liposomes with tretinoin: a physical and chemical evaluation. J Pharm Biomed Anal 2001, 26:909-17.
40. Yarosh D, Klein J, O'Connor A. Effect of topically applied T4 endonuclease V in liposomes on skin cancer in xeroderma pigmentosum: a randomised study. Xeroderma Pigmentosum Study Group. Lancet 2001, 357:926-9.
41. Dubey V, Mishra D, Nahar M. Elastic liposomes mediated transdermal delivery of an anti-jet lag agent: preparation, characterization and in vitro human skin transport study. Curr Drug Deliv 2008, 5:199-206.
42. Cheng Y, Xu Z, Ma M, Xu T. Dendrimers as drug carriers: applications in different routes of drug administration. J Pharm Sci 2008, 97:123-43.
43. http://www.dendrimercenter.org/dendrimers.html, Available from URL: Accessed May 23, 2009
44. Cheng Y, Man N, Xu T. Transdermal delivery of nonsteroidal anti-inflammatory drugs mediated by polyamidoamine (PAMAM) dendrimers. J Pharm Sci 2007, 96:595-602.
45. Wang Z, Itoh Y, Hosaka Y. Novel transdermal drug delivery system with polyhydroxyalkanoate and starburst polyamidoamine dendrimer. J Biosci Bioeng 2003, 95:541-3.
46. Wei C, Wei W, Morris M. Nanomedicine and drug delivery. Med Clin North Am 2007, 91:863-70.
47. Zuo L, Wei W, Morris M. New technology and clinical applications of nanomedicine. Med Clin North Am 2007, 91:845-62.
48. Michalet X, Pinaud FF, Bentolila LA. Quantum dots for live cells, in vivo imaging, and diagnostics. Science 2005, 307:538-44.
49. Nanotechnology Introduction. http://www.nanotech-now.com/introduction.htm, Available from: URL: Accessed March 29, 2009
50. Patel HR. Quantum dots: A novel technique for drug delivery and therapy. 2007, Pharmainfo.com, Vol 5. Issue 6
51. AzoNano.com. http://www.azonano.com/, Available from URL: Accessed May 26, 2009